Area Sanitaria De Ferrol

The Area Sanitaria De Ferrol is conducting a strong body of research in gastroenterology and immunology, focusing on conditions such as Crohn’s disease, ulcerative colitis, and related inflammatory bowel disorders. These studies are aimed at evaluating new therapies, improving long-term disease control, and understanding how treatment responses can be maintained over time.

• Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis
• Fistulizing and moderately to severely active intestinal inflammation
• Testing biologic and targeted treatments for symptom relief and disease remission

Several trials also explore maintenance strategies and safety in both adult and pediatric patients, reflecting a broad effort to improve care across different age groups.

Clinical trials at this site also cover cardiovascular diseases and metabolic disorders, including atherosclerotic cardiovascular disease, heart failure, hypertension, obesity, and type 2 diabetes. The research is centered on preventing major cardiovascular events, lowering blood pressure, and improving risk factor control in people with complex chronic disease.

• Atherosclerotic cardiovascular disease and elevated lipoprotein(a)
• Heart failure, uncontrolled hypertension, and resistant hypertension
• Obesity, type 2 diabetes, and related cardiometabolic risk

These studies are designed to test whether new treatments can reduce complications, support better long-term outcomes, and simplify management for patients with overlapping heart and metabolic conditions.

Research in renal and hepatometabolic disease includes trials in chronic kidney disease, kidney disease linked to type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease. The main goal is to assess therapies that may slow disease progression and improve organ protection in patients with high medical risk.

• Chronic kidney disease, including diabetic and non-diabetic forms
• Metabolic dysfunction-associated steatotic liver disease
• Evaluating treatment combinations and kidney-protective effects

These trials are particularly important for patients with overlapping metabolic and cardiovascular conditions, where preserving kidney function is a key priority.

As a Respiratory Department site, Area Sanitaria De Ferrol is actively involved in studies of chronic obstructive pulmonary disease and other inflammatory respiratory conditions. This research is focused on testing new options that may help improve breathing symptoms, reduce flare-ups, and support better disease control in adults with chronic lung disease.

• Chronic obstructive pulmonary disease and type 2 inflammatory airway disease
• Assessing new therapies for symptom reduction and exacerbation prevention
• Exploring improved treatment approaches for long-term respiratory care

These studies add an important respiratory dimension to the site’s broader clinical research portfolio.

The site also participates in selected studies across oncology and other specialized areas, including colorectal cancer, prostate cancer, and bladder cancer. In addition, there are trials that do not fit neatly into a single therapeutic category, reflecting a diverse research environment.

• Metastatic colorectal cancer and prevention of treatment-related complications
• High-risk prostate cancer and non-muscle-invasive bladder cancer
• Investigating new treatment approaches and supportive care strategies

These studies broaden the site’s clinical research activity beyond chronic inflammatory and cardiometabolic disease, showing a wide-ranging commitment to patient care and innovation.